Severely affected donors exhibited a decrease in NeuN immunostaining, raising some concern that the use of NeuN as a neuronal marker in our FANS protocol could have biased cellular proportions across donors as a function of AD pathology if some neuronal types lost NeuN labeling disproportionately. Here, RBFOX3 is linked to Alzheimer disease.